Alkali Therapy in Chronic Kidney Disease
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.
Also called NCT01452412
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 149 participants
- Sponsor
- Registry
-
NCT01452412
-
- Other papers using this trial's data
- Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01452412. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2016-08 (actual). Results posted on 2020-01-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Alkali Therapy in Chronic Kidney Disease
- Condition
- Chronic Kidney Disease
- Condition
- Metabolic Acidosis
- Intervention (Drug)
- Sodium bicarbonate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Albert Einstein College of Medicine
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator
- National Institutes of Health (NIH)
Record details
- Record id
cardio:ct-nct01452412- Content hash
9fc203269163420bec57d90e27eefee0583c27b6a3b61e4277e320eec0b49b4b